Seeking Alpha

Amarantus Bioscience Holdings, Inc. (AMBS)

From other sites
AMBS vs. ETF Alternatives
Company Description
Amarantus BioScience Holdings (AMBS) is a biotechnology company developing therapeutics and diagnostics for neurological disorders and orphan diseases. AMBS owns licensing rights to the small molecule drug candidate eltoprazine ("eltoprazine"), indicated for Parkinson's disease Levodopa induced... More